Metabolic diseases
Explore the biological mechanisms that drive metabolic disease, from obesity and insulin resistance to diabetes, MASLD, and dyslipidemia, and discover how these interconnected disorders impact whole-body health.
Metabolic diseases encompass a diverse group of inherited and acquired disorders that disrupt the body's ability to regulate and utilize energy, nutrients, and metabolites efficiently. These conditions have become a major global health challenge, driven by rising rates of obesity, sedentary lifestyles, aging populations, and changes in dietary patterns. Although traditionally viewed as distinct diseases, many metabolic disorders share common underlying mechanisms, including insulin resistance, adipose tissue dysfunction, chronic low-grade inflammation, mitochondrial stress, and altered lipid and glucose metabolism. These interconnected pathways create a continuum of metabolic dysfunction that affects multiple organs and physiological systems.
Among the most prevalent metabolic diseases are obesity, type 2 diabetes mellitus (T2D), dyslipidemia, and metabolic dysfunction-associated steatotic liver disease (MASLD). Obesity often serves as the initiating event, characterized by the excessive accumulation of adipose tissue and a progressive loss of normal adipose function. As adipose tissue expands beyond its capacity to safely store lipids, excess fatty acids accumulate in non-adipose organs such as the liver, skeletal muscle, pancreas, and heart, a process known as ectopic lipid deposition. This promotes insulin resistance, a pathological state in which tissues become less responsive to insulin signaling, impairing glucose uptake and metabolic regulation, and is widely recognized as the central mechanistic hub linking many metabolic diseases.
Understanding the shared biological mechanisms linking all these disorders is essential for developing effective prevention strategies and therapies that target the root causes of metabolic dysfunction rather than its individual manifestations.